- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 7 - Increased Monetary Costs of Multiple Sclerosis
During this segment, the panelists discuss the how the trend toward outpatient care and development of disease-modifying therapies for the treatment of multiple sclerosis (MS) has affected costs of care.
Leslie Fish, PharmD, explains that because most treatment options for MS are available through the pharmaceutical side, the costs of medications and entire cost of treatment for MS has risen dramatically since 2010.
Gary M. Owens, MD, agrees and explains a 3 year analysis that compared the direct medical costs of MS to pharmaceutical costs and revealed that 85% of the expenditures for the treatment of MS result on the pharmaceutical side.
Dr Fish continues by explaining how the decrease in the number of hospitalizations is relative to the trend to treat MS in an outpatient care setting.
The panelists conclude the discussion with concerns that as the treatment costs for MS continue to rise, many aspects of treatment aren’t covered, which leaves a huge burden on patients, their caregivers, and family members.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
